Results 51 to 60 of about 1,915,304 (214)

Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis

Frontiers in Cardiovascular Medicine, 2022
BackgroundPercutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small ...
Wen-Rui Ma, Karthik H. Chandrasekharan, Chang-Sheng Nai, Yong-Xiang Zhu, Javaid Iqbal, Shang Chang, You-Wei Cheng, Xin-Yu Wang, Christos V. Bourantas, Yao-Jun Zhang   +9 more
doaj   +1 more source

Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1

BMEMat, EarlyView.
NP‐SF, designed to target macrophage Dectin‐1 and activated platelets, selectively accumulated in ischemic myocardium, where it was taken up by macrophages after platelet hitchhiking. By inhibiting NLRC5‐related PANoptosis, NP‐SF significantly attenuated pathological damage, and effectively preserved cardiac function in a murine ischemia–reperfusion ...
Guanye Yu, Na Yang, Yan Zhang, Lingxin Peng, Yi Li, Yue Chao, Qinfang Miao, Haikun Qi, Jianhui Zhuang, Weixia Jian, Bingyu Li, Wenhui Peng, Jinghua Chen, Shiyu Gong   +13 more
wiley   +1 more source

Plain balloon angioplasty +/- bare metal stenting versus drug-coated balloon angioplasty +/- bare metal stenting versus primary drug-eluting stenting in patients with chronic limb-threatening ischaemia: BASIL-3, an open-label, three-arm, randomised, multi-centre, phase 3 trial

Health Technology Assessment
Objectives To determine which primary endovascular revascularisation strategy represents the most clinical and cost-effective treatment for patients with chronic limb threatening ischaemia who require an endovascular femoro-popliteal, with or without an ...
Matthew A Popplewell, Jack A Hall, Jesse Kigozi, Mishal Javed, Lewis Meecham, Gareth R Bate, Lisa Kelly, Jonathan J Deeks, Catherine A Moakes, Andrew W Bradbury,   +10 more
doaj   +1 more source

Preclinical Serial Assessment of Virtual Physiology After Implantation of a Novel Endoluminal Resorbable Fibrillated Scaffold

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The resorbable fibrillated scaffold (RFS) is a novel electrospun, polylactide‐based endoluminal scaffold developed for peripheral arterial applications. Its porous microfibre architecture is intended to support host cell infiltration and vascular restoration.
Kotaro Miyashita, Lucas Hatzikostas, Emiliano Bianchini, Milosz Dziarmaga, Chun‐Ting Shih, Jouke Dijkstra, Eric K. W. Poon, Bart Sanders, Golo von Basum, Rick de Vries, Kim van Noort, Marc van Sambeek, Jos C. van den Berg, Albert Chinhenzva, Scot Garg, Yoshinobu Onuma, Patrick W. Serruys   +16 more
wiley   +1 more source

Targeted delivery for treatments for restenosis and vein graft disease [PDF]

, 2012
Surgery to restore blood flow in arteries blocked by atherosclerotic plaque is a common treatment in cardiovascular disease. Longtermcomplications of surgical treatment are vein graft disease and restenosis, a renarrowing of the blood vessel after ...
Thomas, Anita C
core   +1 more source

Drug‐Coated Balloon‐Based Strategy for De Novo Coronary Artery Disease Across Complex and High‐Risk Indicated Percutaneous Coronary Intervention Risk Categories: A Multicenter Registry Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Evidence regarding the risk‐stratified effectiveness of drug‐coated balloon (DCB)‐based PCI for de novo coronary artery disease (CAD) remains limited, particularly in patients undergoing complex and high‐risk indicated percutaneous coronary intervention (CHIP PCI).
Dong Oh Kang, Sunwon Kim, Ae‐Young Her, Eun‐Seok Shin   +3 more
wiley   +1 more source

Erratum to: Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial [PDF]

, 2017
Background The use of a drug-eluting balloon for the treatment of de novo coronary artery lesions remains to be evaluated. A previous trial in patients with stable and unstable angina comparing a bare metal stent mounted on a drug-eluting balloon with a
Suh, Jung-Won, In-Ho Chae, Jung-Won Suh, Sang-Don Park, Chae, In-Ho, Yoon, Chang-Hwan, Tae-Jin Youn, Cho, Young-Suk, Youn, Tae-Jin, Il-Young Oh, Park, Sang-Don, Chang-Hwan Yoon, Dong-Ju Choi, Choi, Dong-Ju, Oh, Il-Young, Young-Suk Cho   +15 more
core   +1 more source

Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness

Journal of Pharmacoeconomics and Pharmaceutical Management, 2015
Background: Recent advances in the intravascular diseases have led to the entrance of drug-eluting balloon (DEB) technology. The DEB is a relatively new and easier way to treat vascular stenosis.
Khosro Keshavarz, Amir Hashemi-Meshkini, Pardis Zaboli, Jamal Khedmati, Abbas Kebriaeezadeh   +4 more
doaj  

Drug-Coated Balloons Beyond In-Stent Restenosis

Reviews in Cardiovascular Medicine
Drug-coated balloons (DCBs) are rapidly gaining prominence, owing to the associated expanding clinical applications and therapeutic potential in interventional cardiology. Moreover, a growing body of evidence from randomized trials, observational studies,
Rahul Gupta, Chandrashekar Bohra, Krishna Santosh Vemuri, Gaurav Arora, Amit Gulati, Isha Ranadive, Samin K. Sharma, Amit Hooda   +7 more
doaj   +1 more source

Treatment of acute occlusion due to intracranial atherosclerosis by angioplasty with ELUTAX “3″ drug-eluting balloon

Interdisciplinary Neurosurgery, 2020
Background: Intracranial atherosclerotic disease is an important cause of ischemic stroke due to large vessel occlusion. The acute management of these occlusions is challenging and associates an important risk of complications, especially when mechanical
Blanca Serrano Serrano, Francisco Hernández Fernández, Nicolás López Hernández, Elena Elvira Soler, Giorgio Barbieri, Juan D. Molina Nuevo   +5 more
doaj   +1 more source